Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ascendis Pharma A/S

    NASDAQ: ASND · Real-Time Price · USD
    197.97
    5.93 (3.09%)
    At close: Aug 15, 2025, 3:59 PM
    198.32
    0.18%
    After-hours: Aug 15, 2025, 04:10 PM EDT

    Ascendis Pharma A/S Income Statement

    Financials in EUR. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 363.64M 266.72M 51.17M 7.78M
    Cost of Revenue
    		 44.26M 44.4M 12.14M 3.52M
    Gross Profit
    		 319.38M 222.32M 39.04M 4.25M
    Operating Income
    		 -278.76M -455.54M -561.81M -451.79M
    Interest Income
    		 14.36M 16.86M 7.43M 692K
    Pretax Income
    		 -373.24M -474.14M -577.82M -383.94M
    Net Income
    		 -378.08M -481.45M -583.19M -383.58M
    Selling & General & Admin
    		 284.55M 264.41M 221.23M 160.18M
    Research & Development
    		 307M 413.45M 379.62M 295.87M
    Other Expenses
    		 6.6M n/a n/a n/a
    Operating Expenses
    		 598.15M 677.86M 600.85M 456.05M
    Interest Expense
    		 65.5M 44.06M 30.68M 3.91M
    Selling & Marketing Expenses
    		 n/a 5.62M n/a n/a
    Cost & Expenses
    		 642.4M 722.26M 612.99M 459.57M
    Income Tax Expense
    		 4.84M 7.3M 5.38M -367K
    Shares Outstanding (Basic)
    		 57.89M 56.29M 56.07M 54.77M
    Shares Outstanding (Diluted)
    		 57.89M 56.29M 56.07M 54.77M
    EPS (Basic)
    		 -6.53 -8.55 -10.4 -7
    EPS (Diluted)
    		 -6.53 -8.55 -10.4 -7
    EBITDA
    		 -290.02M -411.17M -529.18M -364.64M
    EBIT
    		 -307.74M -430.08M -547.13M -380.03M
    Depreciation & Amortization
    		 17.71M 18.91M 17.51M 15.39M

    Add to Watchlist